About Src substrate cortactin
Src substrate cortactin (CTTN) is a protein
from Homo sapiens identified by UniProt accession
Q14247, 550 residues long.
MolForge cross-references it against 0 known binders and
322 disease associations.
Target properties
| Protein name | Src substrate cortactin |
| UniProt accession | Q14247 |
| Gene | CTTN |
| Organism | Homo sapiens |
| Length | 550 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (322)
Diseases linked to this target (Open Targets).
- FEV/FVC ratio · score 0.33
- glioblastoma multiforme · score 0.19
- neoplasm · score 0.11
- infection · score 0.09
- infect · score 0.09
- esophageal squamous cell carcinoma · score 0.09
- chronic lymphocytic leukemia · score 0.09
- non-small cell lung carcinoma · score 0.08
- hepatocellular carcinoma · score 0.08
- acute lymphoblastic leukemia · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q14247-F1 | alphafold | PREDICTED | 62.46 | — |
Amino-acid sequence (550 residues)
MWKASAGHAV SIAQDDAGAD DWETDPDFVN DVSEKEQRWG AKTVQGSGHQ EHINIHKLRE NVFQEHQTLK EKELETGPKA SHGYGGKFGV EQDRMDKSAV GHEYQSKLSK HCSQVDSVRG FGGKFGVQMD RVDQSAVGFE YQGKTEKHAS QKDYSSGFGG KYGVQADRVD KSAVGFDYQG KTEKHESQRD YSKGFGGKYG IDKDKVDKSA VGFEYQGKTE KHESQKDYVK GFGGKFGVQT DRQDKCALGW DHQEKLQLHE SQKDYKTGFG GKFGVQSERQ DSAAVGFDYK EKLAKHESQQ DYSKGFGGKY GVQKDRMDKN ASTFEDVTQV SSAYQKTVPV EAVTSKTSNI RANFENLAKE KEQEDRRKAE AERAQRMAKE RQEQEEARRK LEEQARAKTQ TPPVSPAPQP TEERLPSSPV YEDAASFKAE LSYRGPVSGT EPEPVYSMEA ADYREASSQQ GLAYATEAVY ESAEAPGHYP AEDSTYDEYE NDLGITAVAL YDYQAAGDDE ISFDPDDIIT NIEMIDDGWW RGVCKGRYGL FPANYVELRQ
Explore Src substrate cortactin with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets